Treatment of Depression: A Brief History

Similar documents
Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

Frequently Asked Questions FAQS. NeuroStar TMS Therapies

Transcranial Magnetic Stimulation for the Treatment of Depression

Neuromodulation Approaches to Treatment Resistant Depression

DEEP TMS TREATMENT CONSENT FORM

Transcranial Magnetic Stimulation

Remission From Depression Is Possible

Patient Education Brief. NeuroStar TMS Therapies

Statement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17

Some newer, investigational approaches to treating refractory major depression are being used.

FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION

BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies

Transcranial Magnetic Stimulation (TMS)

What is Repetitive Transcranial Magnetic Stimulation?

Repetitive transcranial magnetic stimulation for depression

MIND-CONTROLLED DRONES VIRTUAL REALITY WEIRD INVENTIONS KITCHEN CHEMISTRY

Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.

Are you not responding to antidepressants?

Oscar G. Morales. MD Founding Director McLean Hospital TMS

Repetitive Transcranial Magnetic Stimulation as a for Treatment of Refractory Depression and other Psychiatric/Neurologic Disorders

Setting up a TMS Treatment Program

Bright Nights: Understanding Depression

BRAINSWAY DEEP TMS SYSTEM

a proven non-drug treatment for depression Get back to well without medication side effects right in your doctor s office.

Case 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1

(U) USSOCOM. (U) Magnetic qeeg guided Resonance Therapy (MeRT)

ANTI-DEPRESSANT MEDICATIONS

Bringing. to patients with depression

2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.

NOW I M A NEUROSTAR. Let Your Best Self Shine

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

Zinging the Blues. By Kathy Svitil

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

LEASE DO NOT COPY. Setting up atms Clinic

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

Interventions for Relapsing Depression: TMS, ECT, and Ketamine

TMS: Full Board or Expedited?

Setting up atms Clinic. Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

TRANSCRANIAL MAGNETIC STIMULATION: CLINICAL UPDATE FOR PSYCHIATRIC APPLICATIONS ANNA MAZUR, PH.D. OSU DEPT. OF PSYCHIATRY AND BEHAVIORAL SCIENCES

What is NBS? Nextstim NBS System

Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

obsessive-compulsive disorder; OCD

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Introduction to TMS Transcranial Magnetic Stimulation

Brain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN

Medication Guide Fluoxetine Tablets, USP

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

Transcranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications

Repetitive Transcranial Magnetic Stimulation (rtms)

Deep Brain Stimulation (DBS) For patients with tremor

Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients

Neuromodulation in Dravet Syndrome. Eric BJ Segal, MD Director of Pediatric Epilepsy Northeast Regional Epilepsy Group Hackensack, New Jersey

Depression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people

Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders Corporate Medical Policy

Supplementary Online Content

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Administration of repetitive transcranial magnetic stimulation (rtms)

Medication Guide Fluoxetine Oral Solution USP What is the most important information I should know about fluoxetine oral solution?

AP PSYCH Unit 13.3 Biomedical Therapies

The Next Chapter in Brain Stimulation Therapy

Original Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression

Repetitive transcranial magnetic stimulation (rtms) at Toronto Western Hospital

Depression. Introduction Depression is a common condition that affects millions of people every year.

Corporate Medical Policy

Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder

A Patient s Guide: Pursuing Health Care. Reimbursement. for NeuroStar TMS Therapy

DRUGS THAT ACT IN THE CNS

Optimal Use of Antidepressants: Focusing on SNRI, NDRI and SSRE

Antidepressant Medication Therapy in Primary Care July 25, 2013

Management Of Depression And Anxiety

Deep transcranial magnetic stimulation (dtms) beyond depression

GREATER MANCHESTER INTERFACE PRESCRIBING GROUP

Efficacy and Safety of Transcranial Magnetic Stimulation in Patients with Depression

MEDICATION GUIDE FLUOXETINE CAPSULES USP

Help and Healing: Section 2: Treatment Planning. Treatment and Timelines. Depression Treatment Reference. Care Team Communication

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

HCT Medical Policy. Transcranial Magnetic Stimulation (TMS) for Major Depression Policy # 121 Current Effective Date: 05/24/2016.

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

2013 Virtual AD/HD Conference 1

Noninvasive Neuromodulation Current State & Future Directions

Transcranial Magnetic Stimulation

Transcranial magnetic stimulation for the treatment of major depression

Therapeutic Neuromodulation: Overview of a Novel Treatment Platform

Mood Disorders.

Joe Barton, MA, LPC, NCC National Certified Counselor Faculty Associate, TTUHSC Amarillo Family Medicine Department Barton Behavioral Health

biological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40

Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (CES) as a Treatment of Depression and Other Psychiatric/Neurologic Disorders

The New Clinical Science of ECT

Dr Yong Mo Juin. Consultant. GP Symposium 23rd April 2016

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

Supplementary Online Content

Reference ID:

Major Depression and Anxiety in Adolescents and Adults

Transcription:

2500 82nd Place Urbandale, Ia Treatment of Depression: A Brief History 1960 s to Present Community Based Services SSRI Antidepressants SNRI Antidepressants 1970 s to present 20% of patients do not respond to medication and other traditional treatments 1

IN A MULTICENTER RANDOMIZED CONTROLLED TRIAL USING BRAINSWAY DEEP TMS, PUBLISHED (BY LEVKOVITZ, ET AL) FEBRUARY 2015 IN WORLD PSYCHIATRY, 71% OF SUBJECTS RECEIVING ACTIVE TREATMENT RESPONDED OR REMITTED AT FIVE WEEKS AS MEASURED CHANGES IN HDRS-21 SCORES. AT SIXTEEN WEEKS 76.1 % EITHER RESPONDED OR REMITTED. 5 Weeks 16 Weeks Response Other Remission Response Other Remission Brainsway Deep TMS Brainsway Deep dtms is a non-invasive FDA approved treatment which stimulates the brain regions responsible for depression and obsessive-compulsive disorder. It is a safe, convenient, outpatient procedure done at Compass Clinical Associates. 2

ELECTROMAGNETIC COIL INSIDE A PADDED HELMET. THE H1 COIL IS CAPABLE OF STIMULATING BRAIN REGIONS UP TO SIX CENTIMETERS BELOW THE SCALP. How TMS works. dtms provides neuromodulation which directly stimulates neurons in the area of the brain where depression lives. dtms provides neuromodulation which directly stimulates neurons in the area of the brain where Obsessive-compulsive disorder lives Electromagnetic pulses Helmet based enclosure keeps the magnetic coil in place 3

FARADAY S LAW LIKE AN ELECTRIC MOTOR OR GENERATOR ELECTRICAL CURRENT IS GENERATED IN AN ELECTRIC CIRCUIT ADJACENT TO A PULSED MAGNETIC FIELD ELECTRIC CURRENT IS INDUCED IN TARGETED AREA OF NEURONS IN THE DORSOLATERAL PREFRONTAL CORTEX (DLPFC). THE PREFRONTAL CORTEX IS SHOWN IN GREEN ON THE DIAGRAM BELOW. THE BRAIN IS BOTH A CHEMICAL AND ELECTRICAL SYSTEM: CHEMICALS ARE THE MESSENGERS BETWEEN NEURONS. ELECTRICAL IMPULSES (OR ACTION POTENTIALS) ARE THE MESSAGE. LIKE MORSE CODE, THE MESSAGE IS RELAYED BY THE FREQUENCY OF THE ELECTRICAL IMPULSES. HIGHER FREQUENCIES ARE EXCITATORY. LOWER FREQUENCIES ARE INHIBITORY. THE BRAINSWAY DEEP TMS PROTOCOL FOR MAJOR DEPRESSION IS HIGH FREQUENCY (18 HZ), TELLING THE UNDERACTIVE PART OF THE BRAIN TO STEP UP ITS GAME. 4

The dorsolateral prefrontal cortex has neural connections to the underlying cingulate gyrus which connects to the rest of the limbic system. Abnormalities in the limbic system are correlated with MDD. THE BRAIN REWIRES ITSELF TO LEARN A NEW SKILL. A CONCERT CELLIST S BRAIN HAS PHYSICALLY CHANGED TO ACQUIRE THIS SKILL. BY STIMULATING THE UNDERACTIVE PART OF THE BRAIN RESPONSIBLE FOR DEPRESSION, THE BRAIN LEARNS TO BECOME MORE ACTIVE IN THIS REGION. 5

ELECTROCONVULSIVE THERAPY ELECTRICALLY INDUCED SEIZURE IMPACTS THE ENTIRE BRAIN AND CNS COGNITIVE AND MEMORY DYSFUNCTION ALTERATIONS IN BLOOD PRESSURE PAIN AND DISCOMFORT SEVERAL HOURS, INCLUDING ANESTHESIA AND RECOVERY HOURS TO DAYS FOR RECOVERY OFTEN REQUIRES PARTIAL HOSPITALIZATION (DAY HOSPITAL) DEEP TMS STIMULATES THE SPECIFIC AREA OF THE BRAIN IMPLICATED IN DEPRESSION (LEFT DLPFC) TEMPORARY FATIGUE MILD DISCOMFORT OR HEADACHE 0.2% CHANCE OF SEIZURE 6

SSRIS/SNRIS: IMPACTS NON TARGETED BRAIN REGIONS/FUNCTIONS AND OTHER ORGANS NAUSEA NERVOUSNESS, AGITATION OR RESTLESSNESS DIZZINESS REDUCED SEXUAL DESIRE OR DIFFICULTY REACHING ORGASM OR INABILITY TO MAINTAIN AN ERECTION DROWSINESS INSOMNIA WEIGHT GAIN OR LOSS HEADACHE DRY MOUTH VOMITING DIARRHEA DEEP TMS STIMULATES THE SPECIFIC AREA OF THE BRAIN ASSOCIATED WITH DEPRESSION (LEFT DLPFC) TEMPORARY FATIGUE MILD DISCOMFORT OR HEADACHE 0.2% CHANCE OF SEIZURE. 7

Cortical mapping and motor threshold determination Non-invasive Takes about an hour Includes first dtms treatment Treatment sessions Six weeks Five days a week Sessions are twenty minutes Follow up appointments with Dr. Barlow every three weeks Depression scales weekly (PHQ-9) Maintenance or tapering (twice a week for 3 weeks) Cortical mapping and motor threshold determination Non-invasive Takes about an hour Includes first dtms treatment Treatment sessions 29 sessions within 6 weeks Five days a week Sessions are thirty minutes Follow up appointments with Dr. Barlow every three weeks Yale-Brown Obsessive Compulsive Scale (YBOCS) score, 8

Brainsway dtms is indicated for the treatment of depressive episodes in adult patients suffering from Major Depressive Disorder or OCD who have failed to achieve satisfactory improvement from previous anti-depressant medication or OCD medications. If you are suffering from depression and have had several anti-depressants, fail you, this may be a good treatment option for you. Patients with history of seizure disorder, patients with cardiac pacemakers or any metal implants around the head or neck that are not MRI safe. Wellbutrin (Patients would need to taper off this medication before treatment starts). Patients with concurrent alcohol usage. 9

Just about all insurance companies cover TMS if the patient meets the criteria. Some of plans that cover: Wellmark and all other BCBS plans United Health Care (United Behavioral Health) Aetna Cigna Health Partners Medicare Diagnosis of MDD At least 4 trials of failed antidepressants in 2 different classes or 3 trials of failed antidepressants and 1 augmentation. No history of seizures No metal implants from the chest above that are not MRI safe At least 18 years old 10

Eric Barlow, MD, Psychiatrist Medical Director Compass Clinical Associates, PLLC 11